Saitoh S, Scicli A G, Peterson E, Carretero O A
Department of Medicine, Henry Ford Hospital, Detroit, MI 48202-2689, USA.
Hypertension. 1995 May;25(5):1008-13. doi: 10.1161/01.hyp.25.5.1008.
To test the hypothesis that renal kinins act as natriuretic and diuretic hormones, we examined the effect of inhibiting glandular kallikrein on renal function in normotensive unanesthetized rats during normal sodium intake. To inhibit kallikrein at both the luminal and basolateral sides of the distal nephron, we used Fab fragments of monoclonal antibodies to rat urinary kallikrein (Fab-kallikrein). Fab fragments have advantages over intact IgG: they are filtered through the glomerulus and reach the lumen of the distal nephron, where kallikrein is localized and urinary kinins are released. Furthermore, the Fab fragment-antigen complex does not activate the complement system, avoiding the side effects associated with intact antibodies. Fab-kallikrein effectively blocked generation of kinins in the nephron lumen, decreasing urinary kininogenase activity (kallikrein) by 74% to 85% and kinin excretion by 76% to 79%. Fab-kallikrein induced a 30% decrease in urine volume and a 20% to 40% decrease in urinary sodium excretion but did not alter blood pressure, glomerular filtration rate, or renal blood flow. Although urinary prostaglandin E2 excretion also tended to decrease, this change was slower and of lesser magnitude than those of kinin and kininogenase excretion and did not attain statistical significance after Bonferroni's correction. In controls injected with either vehicle or Fab fragments of monoclonal antibodies to ricin (a vegetable protein not present in mammals), none of these parameters decreased significantly. We conclude that renal kinins participate in the short-term regulation of water and sodium excretion in normotensive unanesthetized rats, acting as diuretic and natriuretic hormones.(ABSTRACT TRUNCATED AT 250 WORDS)
为了验证肾激肽作为利钠和利尿激素的假说,我们研究了在正常钠摄入情况下,抑制腺激肽释放酶对正常血压未麻醉大鼠肾功能的影响。为了在远端肾单位的管腔侧和基底外侧侧均抑制激肽释放酶,我们使用了抗大鼠尿激肽释放酶单克隆抗体的Fab片段(Fab-激肽释放酶)。Fab片段比完整的IgG具有优势:它们可通过肾小球滤过并到达远端肾单位的管腔,激肽释放酶定位于此处且尿激肽在此处释放。此外,Fab片段-抗原复合物不会激活补体系统,避免了与完整抗体相关的副作用。Fab-激肽释放酶有效阻断了肾单位管腔内激肽的生成,使尿激肽原酶活性(激肽释放酶)降低74%至85%,激肽排泄降低76%至79%。Fab-激肽释放酶使尿量减少30%,尿钠排泄减少20%至40%,但未改变血压、肾小球滤过率或肾血流量。尽管尿前列腺素E2排泄也有下降趋势,但这种变化比激肽和激肽原酶排泄的变化更缓慢且幅度更小,经Bonferroni校正后未达到统计学显著性。在注射赋形剂或抗蓖麻毒素(一种哺乳动物中不存在的植物蛋白)单克隆抗体Fab片段的对照组中,这些参数均未显著降低。我们得出结论,肾激肽参与正常血压未麻醉大鼠水和钠排泄的短期调节,作为利尿和利钠激素发挥作用。(摘要截短至250字)